Literature DB >> 7694897

Capillarization and venularization of hepatic sinusoids in porcine serum-induced rat liver fibrosis: a mechanism to maintain liver blood flow.

E Bhunchet1, K Fujieda.   

Abstract

The processes of capillarization and venularization of sinusoids after porcine serum-induced rat liver fibrosis were studied by light and electron microscopy. Accompanying the development of fibrosis in the walls of central veins, most of the sinusoidal outlets collapsed, resulting in the formation of hepatic limiting plates around central veins. A few remaining sinusoids underwent capillarization (the development of a basal lamina and the defenestration of the sinusoidal endothelial cell), followed by venularization (the transformation into venules of sinusoids, characterized by the enlargement of the diameters with the lumina being lined with several endothelial cells, which lose fenestrae and develop a basal lamina). These newly formed venules served to maintain blood flow from sinusoids into central veins and thus have been designated the "outlet venules." Diameters of these venules could reach about 25 microns. They were classified into two types: (a) the septal outlet venules, which developed inside the septa; and (b) the angular outlet venules, which drained blood directly from the parenchyma into the fibrotic central veins at the angles between two septa. Associated with venularization, perisinusoidal stellate cells (fat-storing cells or Ito cells) differentiated to myofibroblasts.

Entities:  

Mesh:

Year:  1993        PMID: 7694897

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  22 in total

1.  CYP11B2 expression in HSCs and its effect on hepatic fibrogenesis.

Authors:  Xu Li; Ying Meng; Xi-Shan Yang; Ping-Sheng Wu; Shu-Mei Li; Wen-Yan Lai
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

2.  sPECAM-1 and sVCAM-1: Role in Pathogenesis and Diagnosis of Chronic Hepatitis C and Association with Response to Antiviral Therapy.

Authors:  Michal Kukla; Krystyna Zwirska-Korczala; Andrzej Gabriel; Ewa Janczewska-Kazek; Agnieszka Berdowska; Andrzej Wiczkowski; Barbara Rybus-Kalinowska; Mariusz Kalinowski; Adam Ziolkowski; Elzbieta Wozniak-Grygiel; Marek Waluga; Blazej Nowak
Journal:  Therap Adv Gastroenterol       Date:  2009-03       Impact factor: 4.409

Review 3.  Antifibrotic therapies in the liver.

Authors:  W Z Mehal; D Schuppan
Journal:  Semin Liver Dis       Date:  2015-05-14       Impact factor: 6.115

4.  Hydrodynamics based transfection in normal and fibrotic rats.

Authors:  Rita Yeikilis; Shunit Gal; Natalia Kopeiko; Melia Paizi; Mark Pines; Filip Braet; Gadi Spira
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

5.  Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia.

Authors:  A R Perez-Atayde; S E Sallan; U Tedrow; S Connors; E Allred; J Folkman
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

Review 6.  Pathogenesis of liver cirrhosis.

Authors:  Wen-Ce Zhou; Quan-Bao Zhang; Liang Qiao
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

7.  Atherofibrosis - a unique and common process of the disease pathogenesis of atherosclerosis and fibrosis - lessons for biomarker development.

Authors:  Efstathios Vassiliadis; Natasha Barascuk; Morten A Karsdal
Journal:  Am J Transl Res       Date:  2013-01-21       Impact factor: 4.060

8.  Angiostatin inhibits experimental liver fibrosis in mice.

Authors:  J Mathys Vogten; Tamas A Drixler; Elisabeth A te Velde; Marguerite E Schipper; Theo J M V van Vroonhoven; Emile E Voest; Inne H M Borel Rinkes
Journal:  Int J Colorectal Dis       Date:  2004-01-10       Impact factor: 2.571

Review 9.  Brothers and sisters: molecular insights into arterial-venous heterogeneity.

Authors:  Julius Aitsebaomo; Andrea L Portbury; Jonathan C Schisler; Cam Patterson
Journal:  Circ Res       Date:  2008-10-24       Impact factor: 17.367

Review 10.  Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions.

Authors:  Yasuko Iwakiri; Vijay Shah; Don C Rockey
Journal:  J Hepatol       Date:  2014-06-06       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.